Niki BioSolutions, Inc.
Niki BioSolutions, Inc.
Your view on NIKI
Overview
What the company does, where it operates, and who runs it.
About Niki BioSolutions, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chung Yuen Huen
- Headquarters
- 116 Village Boulevard, Suite 200, Princeton, NJ, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chung Yuen Huen
- Headquarters
- 116 Village Boulevard, Suite 200, Princeton, NJ, US
Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets.
Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Niki BioSolutions, Inc. from FRC's valuation model, read against the market price. NIKI last traded at $1.70; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Niki BioSolutions, Inc.. Starting points for Niki BioSolutions, Inc.: EPS -$18.54, beta 0.17 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Niki BioSolutions, Inc.. Niki BioSolutions, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Niki BioSolutions, Inc.. Trailing twelve-month EPS for Niki BioSolutions, Inc. stands at -$18.54. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings Estimate
| EPS | Current QtrMar 2025 | Current YearFY Dec 2026 |
|---|---|---|
| Avg. estimate | -$27.00 | $31.00 |
| Low estimate | -$27.00 | $31.00 |
| High estimate | -$27.00 | $31.00 |
| No. of analysts | 1 | 1 |
| Year-ago EPS | — | -$19.00 |
| Growth | — | +263.2% |
Revenue Estimate
| Revenue | Current QtrMar 2025 | Current YearFY Dec 2026 |
|---|---|---|
| Avg. estimate | $1.30M | $106.80M |
| Low estimate | $1.30M | $106.80M |
| High estimate | $1.30M | $106.80M |
| No. of analysts | 1 | 1 |
| Year-ago revenue | — | $0.00 |
| Growth | — | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Niki BioSolutions, Inc.. Niki BioSolutions, Inc. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Niki BioSolutions, Inc. valued side by side against its closest peers. Niki BioSolutions, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Niki BioSolutions, Inc. executives and directors. Shares of Niki BioSolutions, Inc. have traded between $6.00 and $44.70 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Niki BioSolutions, Inc.. Coverage tracks Niki BioSolutions, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Niki BioSolutions, Inc.